Announcements Trials
Browse Landscape

Status

Recruiting 4Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 13Glioblastoma 6Glioma 5Epilepsy 5Stroke 3Pheochromocytoma 3Parkinson Disease 3Paraganglioma 3Neuroblastoma 3Neoplasms 3Speech 2Neurofibromatosis 1 2Neurofibroma 2Multiple Sclerosis 2Migraine Disorders 2Lung Neoplasms 2Diabetes Mellitus 2Carcinoma, Non-Small-Cell Lung 2Amyotrophic Lateral Sclerosis 2Adrenal Gland Neoplasms 2Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1Spinal Cord Injuries 1Skin Neoplasms 1Restless Legs Syndrome 1Renal Insufficiency, Chronic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Hearing Loss × CNS × Clear all
NCT07503613 2026-04-06

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Akouos, Inc.

Enrolling by invitation
100 enrolled
CNS

Neuroma, Acoustic, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡